| scholarly article | Q13442814 |
| P50 | author | David Ramírez | Q85908087 |
| P2093 | author name string | David Ramírez | |
| P2860 | cites work | α-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies | Q24632720 |
| DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases | Q27231136 | ||
| Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs | Q27618667 | ||
| ZINC--a free database of commercially available compounds for virtual screening | Q27656255 | ||
| Virtual Screening for UDP-Galactopyranose Mutase Ligands Identifies a New Class of Antimycobacterial Agents | Q27657362 | ||
| AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading | Q27860652 | ||
| Gaussian docking functions | Q28208578 | ||
| Development and validation of a genetic algorithm for flexible docking | Q28236574 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy | Q28251042 | ||
| Automated docking of flexible ligands: applications of AutoDock | Q28285420 | ||
| Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design | Q28366780 | ||
| Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes | Q29616736 | ||
| Improved protein-ligand docking using GOLD | Q29616787 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening | Q29617343 | ||
| Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis. | Q30328211 | ||
| RosettaLigand docking with full ligand and receptor flexibility. | Q51861937 | ||
| An automated method for dynamic ligand design. | Q52322027 | ||
| The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses. | Q52387848 | ||
| GenStar: a method for de novo drug design. | Q52401172 | ||
| MOLMAKER: de novo generation of 3D databases for use in drug design | Q70937787 | ||
| CONCERTS: dynamic connection of fragments as an approach to de novo ligand design | Q71121696 | ||
| Virtual Screening for Bioactive Molecules by Evolutionary De Novo Design Special thanks to Neil R. Taylor for his help in preparation of the manuscript | Q73228331 | ||
| Improving Docking Accuracy through Molecular Mechanics Generalized Born Optimization and Scoring | Q86841260 | ||
| Computer design of bioactive molecules: a method for receptor-based de novo ligand design | Q38534207 | ||
| Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design | Q38558776 | ||
| FOUNDATION: a program to retrieve all possible structures containing a user-defined minimum number of matching query elements from three-dimensional databases | Q38565532 | ||
| Computational Insights of the Interaction among Sea Anemones Neurotoxins and Kv1.3 Channel | Q38968358 | ||
| Docking and virtual screening to identify PKC agonists: potentials in anticancer therapeutics | Q39330231 | ||
| Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors | Q39915822 | ||
| Lead expansion and virtual screening of Indinavir derivate HIV-1 protease inhibitors using pharmacophoric - shape similarity scoring function | Q41918686 | ||
| In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter | Q42010190 | ||
| Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. | Q42540769 | ||
| Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation | Q43987901 | ||
| Functionality maps of binding sites: a multiple copy simultaneous search method | Q44440703 | ||
| Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease | Q44640384 | ||
| Analysing molecular polar surface descriptors to predict blood-brain barrier permeation | Q44702962 | ||
| Protein flexibility in ligand docking and virtual screening to protein kinases. | Q44786754 | ||
| Theory of docking scores and its application to a customizable scoring function | Q44825264 | ||
| FlexX-Scan: fast, structure-based virtual screening | Q45070169 | ||
| Performance of the MM/GBSA scoring using a binding site hydrogen bond network-based frame selection: the protein kinase case. | Q45188356 | ||
| Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors. | Q45959420 | ||
| De novo design of enzyme inhibitors by Monte Carlo ligand generation | Q46260419 | ||
| Pharmacophore based virtual screening, molecular docking and biological evaluation to identify novel PDE5 inhibitors with vasodilatory activity | Q46510461 | ||
| CAVEAT: a program to facilitate the design of organic molecules | Q46602190 | ||
| BUILDER v.2: improving the chemistry of a de novo design strategy | Q46836531 | ||
| Discovery of a pharmacologically active antagonist of the two-pore-domain potassium channel K2P9.1 (TASK-3). | Q48283087 | ||
| Virtual screening and fast automated docking methods. | Q30329412 | ||
| High-throughput crystallography for lead discovery in drug design. | Q30331190 | ||
| Comparison of topological, shape, and docking methods in virtual screening. | Q30362572 | ||
| Docking challenge: protein sampling and molecular docking performance | Q30607323 | ||
| The Protein Data Bank and the challenge of structural genomics | Q30620508 | ||
| Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors | Q30628860 | ||
| The Protein Data Bank and structural genomics | Q30760747 | ||
| De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks | Q30885899 | ||
| Peptide design by artificial neural networks and computer-based evolutionary search | Q32000547 | ||
| The computer program LUDI: a new method for the de novo design of enzyme inhibitors | Q33214112 | ||
| Virtual screening in drug discovery -- a computational perspective | Q33294074 | ||
| Docking: successes and challenges | Q33389996 | ||
| The double-helix microscope super-resolves extended biological structures by localizing single blinking molecules in three dimensions with nanoscale precision. | Q34253342 | ||
| HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site | Q34324246 | ||
| Docking and scoring in virtual screening for drug discovery: methods and applications | Q34364227 | ||
| Multidrug resistance protein P-gp interaction with nanoparticles (fullerenes and carbon nanotube) to assess their drug delivery potential: a theoretical molecular docking study. | Q34374922 | ||
| In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions | Q34414201 | ||
| Computer-based de novo design of drug-like molecules | Q34438895 | ||
| Rational drug design | Q35008284 | ||
| Structure-based virtual screening: an overview | Q35053155 | ||
| Identification of 1,2,5-oxadiazoles as a new class of SENP2 inhibitors using structure based virtual screening | Q35089831 | ||
| Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents | Q35108206 | ||
| Study of the affinity between the protein kinase PKA and peptide substrates derived from kemptide using molecular dynamics simulations and MM/GBSA. | Q35294145 | ||
| ZINCPharmer: pharmacophore search of the ZINC database | Q36088378 | ||
| ChemBank: a small-molecule screening and cheminformatics resource database | Q36454111 | ||
| Prediction of protein-ligand interactions. Docking and scoring: successes and gaps | Q36605327 | ||
| PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules | Q36703753 | ||
| GroupBuild: a fragment-based method for de novo drug design | Q36784871 | ||
| PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology | Q36852276 | ||
| Challenges and advances in computational docking: 2009 in review | Q37848281 | ||
| Molecular dynamics of protein kinase-inhibitor complexes: a valid structural information | Q38008740 | ||
| De novo design: balancing novelty and confined chemical space | Q38029143 | ||
| Latest developments in molecular docking: 2010-2011 in review | Q38092807 | ||
| Computational methods for drug design and discovery: focus on China | Q38137563 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 7-20 | |
| P577 | publication date | 2016-04-26 | |
| P1433 | published in | The open medicinal chemistry journal | Q27722365 |
| P1476 | title | Computational Methods Applied to Rational Drug Design | |
| P478 | volume | 10 |
| Q48260352 | Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors |
| Q64268541 | Approaches to the Structure-Based Design of Antivirulence Drugs: Therapeutics for the Post-Antibiotic Era |
| Q90663872 | Bio-Inspired Strategies for Improving the Selectivity and Sensitivity of Artificial Noses: A Review |
| Q47261017 | Computational Studies of Snake Venom Toxins. |
| Q58696173 | HCN Channels: New Therapeutic Targets for Pain Treatment |
| Q88518698 | Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data? |
Search more.